维普中文期刊产品整合服务
562篇 您的检索式:作者名="Urbanek"
    题名 作者 年代 出处 被引量
1Osteopontin: A non-invasive parameter of portal hypertension and prognostic marker of cirrhosis显示文摘AIM: To investigate the relationship between osteopontin plasma concentrations and the severity of portal hypertension and to assess osteopontin prognostic value.METHODS: A cohort of 154 patients with confirmed liver cirrhosis(112 ethylic, 108 men, age 34-72 years)were enrolled in the study. Hepatic venous pressure gradient(HVPG) measurement and laboratory and ultrasound examinations were carried out for all patients. HVPG was measured using a standard catheterization method with the balloon wedge technique. Osteopontin was measured using the enzyme-linked immunosorbent assay(ELISA) method in plasma. Patients were followed up with a specific focus on mortality. The control group consisted of 137 healthy age- and sex- matched individuals.RESULTS: The mean value of HVPG was 16.18 ± 5.6 mm Hg. Compared to controls, the plasma levels of osteopontin in cirrhotic patients were significantly higher(P < 0.001). The plasma levels of osteopontin were positively related to HVPG(P = 0.0022, r = 0.25) and differed among the individual Child-Pugh groups of patients. The cut-off value of 80 ng/m L osteopontin distinguished patients with significant portal hypertension(HVPG above 10 mm Hg) at 75% sensitivity and 63% specificity. The mean follow-up of patients was 3.7 ± 2.6 years. The probability of cumulative survival was 39% for patients with HVPG > 10 mm Hg and 65% for those with HVPG ≤ 10 mm Hg(P = 0.0086, odds ratio(OR), 2.92, 95% confidence interval(CI): 1.09-7.76). Osteopontin showed a similar prognostic value to HVPG. Patients with osteopontin values above 80 ng/m L had significantly lower cumulative survival compared to those with osteopontin ≤ 80 ng/m L(37% vs 56%, P = 0.00035; OR = 2.23, 95%CI: 1.06-4.68).CONCLUSION: Osteopontin is a non-invasive parameter of portal hypertension that distinguishes patients with clinically significant portal hypertension. It is a strong prognostic factor for survival.Radan Bruha Marie Jachymova Jaromir Petrtyl Karel Dvorak Martin Lenicek Petr Urbanek Tomislav Svestka Libor Vitek 2016World Journal of Gastroenterology2016,22,12:20
2Ultrasound-assessed non-culprit and culprit coronary vessels differ by age and gender显示文摘AIM: To investigate age-and gender-related differences in non-culprit versus culprit coronary vessels assessed with virtual histology intravascular ultrasound (VH-IVUS). METHODS: In 390 patients referred for coronary angiography to a single center (Luzerner Kantonsspital, Switzerland) between May 2007 and January 2011, 691 proximal vessel segments in left anterior descending, circumflex and/or right coronary arteries were imaged by VH-IVUS. Plaque burden and plaque composition(fibrous, fibro-fatty, necrotic core and dense calcium volumes) were analyzed in 3 age tertiles, according to gender and separated for vessels containing non-culprit or culprit lesions. To classify as vessel containing a culprit lesion, the patient had to present with an acute coronary syndrome, and the VH-IVUS had to be performed in a vessel segment containing the culprit lesion according to conventional coronary angiography. RESULTS: In non-culprit vessels the plaque burden increased significantly with aging (in men from 37% ± 12% in the lowest to 46% ± 10% in the highest age tertile, P < 0.001; in women from 30% ± 9% to 40% ± 11%, P < 0.001); men had higher plaque burden than women at any age (P < 0.001 for each of the 3 age tertiles). In culprit vessels of the lowest age tertile, plaque burden was significantly higher than that in non- culprit vessels (in men 48% ± 6%, P < 0.001 as compared to non-culprit vessels; in women 44% ± 18%, P = 0.004 as compared to non-culprit vessels). Plaque burden of culprit vessels did not significantly change during aging (plaque burden in men of the highest age tertile 51% ± 9%, P = 0.523 as compared to lowest age tertile; in women of the highest age tertile 49% ± 8%, P = 0.449 as compared to lowest age tertile). In men, plaque morphology of culprit vessels became increasingly rupture-prone during aging (increasing percentages of necrotic core and dense calcium), whereas plaque morphology in non-culprit vessels was less rupture-prone and remained constant during aging. In women, necrotic core in non-culprit vessels was very low at young age, but increased during aging resulting in a plaque morphology that was very similar to men. Plaque morphology in culprit vessels of young women and men was similar. CONCLUSION: This study provides evidence that age-and gender-related differences in plaque burden and plaque composition significantly depend on whether the vessel contained a non-culprit or culprit lesion.Andreas W Schoenenberger Nadja Urbanek Stefan Toggweiler Andreas E Stuck Thérèse J Resink Paul Erne 2013World Journal of Cardiology2013,5,3:7
3Varation in resistin gene promoter not associated with polycystic ovary syndrome 显示文摘Urbanek M Du Y Silander K 2003Diabetes2003,52,1:1
4Cardiac stem cells delivered intravascularly traverse the vessel barrier,regenerate infarcted myocardium,and improve cardiac function显示文摘 STEIN AB URBANEK K et al 2005Proc Natl Acad Sci U S A2005,102,10:1
5A single nucleotide polymorphism in the matrix metalloproteinase-1 ( MMP-1 ) promoter influences amnion cell MMP-1 expression and risk for preterm premature rupture of the fetal membranes 显示文摘Fujimoto T Parry S Urbanek M 2002J Biol Chem2002,277,8:1
6Cardiomyogenesis in the adult human heart显示文摘Kajstura J Urbanek K Perl S 2010Circ Res2010,107,2:1
7Cardiac stem cells delivered intravascularly traverse the vessel barriet, regenerate infarcted myocardium, and improve cardiac function 显示文摘Dawn B Stein AB Urbanek K 2005Proc Natl Acad Sci USA2005,102,10:1
8Common infections and the risk of stroke显示文摘Grau A J C Urbanek F Palm 2010Nat Rev Neurol2010,6,12:1
9Facial paresis after stroke and its impact on patients' facial movement and mental sta- tus 显示文摘Konecny P Elfmark M Urbanek K 2011J Rehabil Med2011,43,:1
10Intense myocyte formation from cardiac stem ceils in human cardiac hypertrophy显示文摘Urbanek K Quaini F Tasca G 2003Proc Natl Acad Sci USA2003,100,10:1
11Time-frequency approach to extraction of selected second-order cyclostationary vibration components for varying operational conditions显示文摘URBANEK J BARSZCZ T ANTONI J 2013Measurement2013,46,4:1
12Evidence that human cardiac myocytes divide after myocardial infarction显示文摘Beltrami AP Urbanek K Kajstura J 2001N-Engl-J-Med2001,344,23:1
13Cardiac stem cells delivered intravascularly traverse the vessel barrier,regenerate infracted myocardium,and improve cardiac function显示文摘DAWN B STEIN A B URBANEK K 2005Proc Natl Acad Sci USA2005,102,10:1
14Evidence thathuman cardiac myocytes divide after myocardial infarction显示文摘Beltrami A P Urbanek K Kajstura J 2001NEngl J Med2001,344,23:1
15Evidence that human cardiac myocytes divide after myocardial infarction显示文摘Beltrami AP Urbanek K Kajstura J 2001N Engl J Med2001,344,:1
16Mammaglobin gene expression: a superior marker of breast cancer cells in peripheral blood in comparison to epidermal-growth-faclor receptor and cytokeratin-19 显示文摘Granewald K Haun M Urbanek M 2000Lab Invest2000,80,7:1
17Chimerism of the transplanted heart显示文摘Quaini F Urbanek K Beltrami AP 2002N Engl J Med2002,346,:1
18Cardiac stem cells possess growth facto receptor systems that after activation regenerate the infarcted myoeardium,improving ventricular function and long-term survival显示文摘Urbanek K Rota M Cascapera S 2005Circ Res2005,97,7:1
19Diabetes Promotes Cardiac Stem Cell Aging and Heart Failure, Which Are Prevented by Deletion of the p66shc Gene显示文摘Marcello Rota Nicole LeCapitaine Toru Hosoda Alessandro Boni Antonella De Angelis Maria Elena Padin-Iruegas Grazia Esposito Serena Vitale Konrad Urbanek Claudia Casarsa Marco Giorgio Thomas F. Lüscher Pier Giuseppe Pelicci Piero Anversa Annarosa Leri Jan 2006Circulation Research2006,,1:1
20The influence of antibi otic use on the occurrence of vancomycin resistant enterococci显示文摘Kolar M Urbanek K Vagnerova I 2006J Clin Pharm Ther2006,31,1:1
返回顶部 每页显示:
共29页 首页 上一页 第1页 下一页 末页 /29 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费